Filing Details

Accession Number:
0001209191-18-014220
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-02-27 18:41:09
Reporting Period:
2018-02-26
Accepted Time:
2018-02-27 18:41:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1001233 Sangamo Therapeutics Inc SGMO Biological Products, (No Disgnostic Substances) (2836) 680359556
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1547959 Saira Ramasastry C/O Sangamo Therapeutics, Inc.
Point Richmond Tech Ctr, 501 Canal Blvd.
Richmond CA 94804
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-02-26 9,450 $5.03 9,450 No 4 M Direct
Common Stock Disposition 2018-02-26 9,450 $24.88 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2018-02-26 9,450 $0.00 9,450 $5.03
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2022-06-20 No 4 M Direct
Footnotes
  1. The price reported is a weighted average price. The shares were sold at prices ranging from $24.85 to $24.905 The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  2. Option is fully vested and exercisable.